年間 6 号発行
ISSN 印刷: 1040-8401
ISSN オンライン: 2162-6472
Indexed in
Tuning the Rheostat of the Myelopoietic System via Fas and TRAIL
要約
During the last decade, the concerted effort of numerous scientific groups has expanded our understanding of the finely tuned network present within bone marrow for the regulation of the hematopoietic system. This network, comprising humoral and cellular cross talk, is responsible for the adaptation of hematopoietic populations to demands as they arise. Major components of this control system are death receptors and their specific ligands, which eliminate superfluous cells once they have fulfilled their respective functions. The important role of Fas (CD95/Apo-1), one member of this death receptor family, in the regulation of T- and B-cell functions has been established. Alteration of Fas expression and/or function in lymphoid cells may contribute to the development of autoimmunity and/or neoplastic diseases. In addition to controlling lymphoid compartments, Fas is also involved in the regulation of myeloid cell functions. More recently, tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) and its specific receptors (TRAIL-R) have been identified as further members of this death receptor/ligand family. The TRAIL-R/TRAIL system is of vital importance for the maturation and functioning of immune effector cells of lymphoid, as well as myeloid, origin. In the present review, we have summarized current knowledge about both death receptor/ligand systems in the expansion and functioning of cells from the myeloid compartments, highlighted their role in normal hematopoiesis, and assessed their alterations in pathologic or neoplastic conditions.
-
Melloni Elisabetta, Secchiero Paola, Celeghini Claudio, Campioni Diana, Grill Vittorio, Guidotti Lia, Zauli Giorgio, Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development, Journal of Cellular Physiology, 204, 3, 2005. Crossref
-
Antel Jack P., Miron Veronique E., Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies, Clinical Neurology and Neurosurgery, 110, 9, 2008. Crossref
-
Leong Sai Mun, Tan Ban Xiong, Bte Ahmad Baidah, Yan Tie, Chee Lai Yuen, Ang Swee Tin, Tay Kian Ghee, Koh Liang Piu, Yeoh Allen Eng Juh, Koay Evelyn Siew-Chuan, Mok Yu-Keung, Lim Tit Meng, Mutant nucleophosmin deregulates cell death and myeloid differentiation through excessive caspase-6 and -8 inhibition, Blood, 116, 17, 2010. Crossref
-
de Luca Bianca, Xavier-Elsas Pedro, Barradas Mônica, Luz Ricardo A., Queto Túlio, Jones Carla, Arruda Maria Augusta, Cunha Thiago Mattar, Cunha Fernando Queiroz, Gaspar-Elsas Maria Ignez, Essential Roles of PKA, iNOS, CD95/CD95L, and Terminal Caspases in Suppression of Eosinopoiesis by PGE2 and Other cAMP-Elevating Agents, The Scientific World Journal, 2013, 2013. Crossref
-
Mizrahi Keren, Askenasy Nadir, Physiological functions of TNF family receptor/ligand interactions in hematopoiesis and transplantation, Blood, 124, 2, 2014. Crossref
-
Yi Sha, Wen Lu, He Jing, Wang Youping, Zhao Fei, Zhao Jie, Zhao Zichu, Cui Guohui, Chen Yan, Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation, Annals of Hematology, 94, 2, 2015. Crossref
-
Greil Richard, Hutterer Evelyn, Hartmann Tanja Nicole, Pleyer Lisa, Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation, Cell Communication and Signaling, 15, 1, 2017. Crossref
-
Pleyer Lisa, Neureiter Daniel, Faber Victoria, Greil Richard, Myelodysplastic Syndromes (MDS), in Chronic Myeloid Neoplasias and Clonal Overlap Syndromes, 2010. Crossref
-
Pleyer Lisa, Greil Richard, Introduction to “Classic” Chronic Myeloproliferative Disorders (CMPDs) — Molecular and Cellular Biology, in Chronic Myeloid Neoplasias and Clonal Overlap Syndromes, 2010. Crossref
-
Pleyer Lisa, Neureiter Daniel, Greil Richard, Clonal Bone Marrow Failure Overlap Syndromes, in Chronic Myeloid Neoplasias and Clonal Overlap Syndromes, 2010. Crossref
-
Barrett A. John, Sloand Elaine, Young Neal S., Immunologic mechanisms and treatment of myelodysplastic syndromes, in Myelodysplastic Syndromes, 2005. Crossref
-
Ernst Patricia, Hematopoietic Stem Cells, in Molecular Basis of Hematopoiesis, 2009. Crossref
-
Pearl-Yafe Michal, Stein Jerry, Yolcu Esma S., Farkas Daniel L., Shirwan Haval, Yaniv Isaac, Askenasy Nadir, Fas Transduces Dual Apoptotic and Trophic Signals in Hematopoietic Progenitors, Stem Cells, 25, 12, 2007. Crossref
-
Pearl-Yafe Michal, Mizrahi Keren, Stein Jerry, Yolcu Esma S., Kaplan Ofer, Shirwan Haval, Yaniv Isaac, Askenasy Nadir, Tumor Necrosis Factor Receptors Support Murine Hematopoietic Progenitor Function in the Early Stages of Engraftment, Stem Cells, 28, 7, 2010. Crossref
-
Pearl-Yafe Michal, Yolcu Esma S., Stein Jerry, Kaplan Ofer, Shirwan Haval, Yaniv Isaac, Askenasy Nadir, Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis, Experimental Hematology, 35, 10, 2007. Crossref
-
Mizrahi K, Stein J, Pearl-Yafe M, Kaplan O, Yaniv I, Askenasy N, Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation, Leukemia, 24, 7, 2010. Crossref